How to Buy Amneal Pharmaceuticals Stock
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals, Inc. , together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas.
Amneal Pharmaceuticals stock last closed at $5.87, down 0.51% from the previous day, and has increased 224.31% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 2.31 percentage points. Amneal Pharmaceuticals stock is currently +237.36% from its 52-week low of $1.74, and -9.13% from its 52-week high of $6.46.
As of Apr 26, 2024, there are 307.01M shares of AMRX outstanding. The market capitalization of AMRX is $1.80B. In the past 24 hours, 959,053 AMRX shares were traded.
How to Buy Amneal Pharmaceuticals Stock
Not sure how to invest in Amneal Pharmaceuticals stock? Here's how.
- Choose where to buy Amneal Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Amneal Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Choose your method of payment and add your info.
- Evaluate Amneal Pharmaceuticals stock: The Amneal Pharmaceuticals ticker symbol is AMRX. Is Amneal Pharmaceuticals stock a good investment? Should you buy shares of AMRX? How do AMRX's underlying business fundamentals look? Do top analysts think Amneal Pharmaceuticals is a good buy? Why has AMRX's stock price moved recently? (Hint: Our stock market research website can help you evaluate if AMRX is a good stock to buy).
- Place your AMRX buy order: Decide if you will purchase AMRX shares at the current market price or use a limit order to purchase AMRX shares at a given price.
- Keep an eye on your investment in AMRX: Create a watchlist to important notifications about your investment in Amneal Pharmaceuticals shares.
Step 1: Choose where to buy Amneal Pharmaceuticals stock
You need an online brokerage account in order to access the NASDAQ market and buy AMRX stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal details so you are able to buy AMRX today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've opened your account on one of the most highly reviewed stock market apps, you need to deposit funds:
Check out the tutorial below for more details depositing funds into your investment account.
Step 4: Evaluate Amneal Pharmaceuticals stock
After you have decided on the best place to buy Amneal Pharmaceuticals stock, it's very important to analyze their stock prior to buying, so you can comprehend the risk as well as the opportunity.
Amneal Pharmaceuticals stock quick numbers
AMRX Zen Score
WallStreetZen was created to help average investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on AMRX's stock page.
Is AMRX stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge AMRX's true value.
Using relative valuations methods:
- AMRX could be overvalued based on its P/B ratio of 91.1x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.09x
You can access additional valuation research on AMRX's stock here.
AMRX Financial Health
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the AMRX balance sheet.
- AMRX profit margin has gone up from -5.9% to -3.5% in the past year.
Negative Financial Indicators:
- AMRX earnings of $135.09M is not sufficient to cover its interest payments.
- There are more long-term liabilities than short-term assets on the AMRX balance sheet.
- AMRX has a relatively high debt to equity ratio of 174.54.
- Total AMRX debt is higher than 5 years ago, relative to shareholder equity.
- AMRX's operating cash flow of $345.58M allows it to safely service it's debt of $2.75B.
Is AMRX stock a Buy, Hold, or Sell, according to analysts?
Out of 4 Equities analysts who give forecasts on AMRX, the consensus analyst rating on AMRX is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Amneal Pharmaceuticals stock forecast page.
AMRX Momentum
AMRX Growth Metrics
Last year, AMRX revenue was $2.39B. During the past five year, AMRX's revenue has gone up by 7.56% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.65%.
You can analyze AMRX's earnings and revenue performance here.
What are AMRX executives and large shareholders up to?
In the past 12 months, executives and large shareholders at AMRX have sold more shares than they have bought.
Tasos Konidaris, Executive Vice President CFO of AMRX, was the latest AMRX insider to sell. They sold $163,494.90 worth of AMRX shares on Mar 12, 2024.
Get more info about who owns AMRX shares here.
Can I get consistent income from AMRX stock?
No, Amneal Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about AMRX?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your AMRX buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, place a limit order.
Click the Open button and your broker will place the order.
If you require additional info about investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your investment in AMRX
Now that you own some AMRX stock, you'll want to keep up with your shares.
Add AMRX to a watchlist to track the most important metrics related to your AMRX stock.
AMRX Feed
How to Buy Stock in Amneal Pharmaceuticals
To summarize, here are the 6 steps to buy stock in Amneal Pharmaceuticals:
- Choose where to buy Amneal Pharmaceuticals stock
- Create your brokerage account
- Deposit money your investment account
- Evaluate Amneal Pharmaceuticals stock
- Place your AMRX buy order
- Keep an eye on your investment in AMRX
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Amneal Pharmaceuticals, create a watchlist today.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.